CLINICAL FEATURES, RELATED FACTORS AND EVALUATE OF TINEA PEDIS TREATMENT RESULTS WITH TERBINAFINE AT CAN THO DERMATO-VENEREOLOGY HOSPITAL IN 2019-2020
Main Article Content
Abstract
Background: Tinea pedis is a popular disease that makes patients itchy and uncomfortable, causing difficulties in daily life and affecting health. Terbinafine 1% is an antifungal drug of the allylamine group, it has a good effect on tinea pedis patients. In Vietnam, there are few studies about the results of tinea pedis using terbinafine and side effects of the drug. Therefore, it is really necessary to evaluate of tinea pedis treatment results with terbinafine. Objective: Describe clinical features, related factors and evaluate the results of tinea pedis using terbinafine at Can Tho hospital of dermato-venereology 2020-2021. Materials and methods: A cross – sectional study with analysis. A total of 140 patients tinea pedis participated in the study at Can Tho Dermato-Venereology Hospital. Results: 140 patients with tinea pedis: 60.7% male and 39.3% female, average age is 34.84±13.91 years, functional symptoms: 81.4% itching, 43.6% increased sweating, 16.4% pain, the basic lesions: 93.6% red inlaid, 69.3% skin scales,60.0% blisters,30.7% cracked, 20.0% lesion area >400cm2, the severity of the disease was on average 64.3%; there is an association between tinea pedis with habit of playing sports, habit of wearing shoes, socks and increased sweating. After 4 weeks, the results of tinea pedis using terbinafine are good at 81.4%, average at 18.6% and 0.0% least. Conclusion: Terbinafine is effective in treating tinea pedis.
Article Details
Keywords
tinea pedis, terbinafine
References
2. Bộ Y Tế Bộ (2015), Quyết định: Về việc ban hành tài liệu chuyên môn “Hướng dẫn chẩn đoán và điều trị các bệnh da liễu” Quyết định số 75/QĐ-BYT ngày 13 tháng 01 năm 2015.
3. Trần Hậu Khang (2014), Bệnh học da liễu, Sách đào tạo sau đại học, NXB Y học
4. Nguyễn Minh Thu (2012), Nghiên cứu tình hình nấm bàn chân tại Bệnh viện Da liễu Trung ương năm 2012, Luận văn Bác sĩ Nội trú,Trường Đại học Y Dược Hà Nội, Cần Thơ.
5. Berman B, Ellis C, et al (1992), "Efficacy of a 1-week, twice-daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis. Results of placebo-controlled, doubleblind, multicenter trials", J Am Acad Dermatol, 26 (6), pp 956-960.
6. Crawford F, Hollis S (2007), "Topical treatments for fungal infections of the skin and nails of the foot.", Cochrane Database Syst Rev, 18 (3), pp.CD001434.
7. De Chauvin MF, Viguié Vallanet C, Et al (2007), "Novel, single dose, topical treatment of tinea pedis using terbinafine: results of a dose finding clinical trial", Mycoses, 51 (1), pp 1-6.
8. Eisman S, Sinclair R (2014), "Fungal nail infection: diagnosis and management", BMJ, 348, pp 1-11.
9. Evans EG, Dodman B, et al (1993), "Comparison of terbinafine and clotrimazole in treating tinea pedis", BMJ, 307 (6905), pp 645-647.
10. Hiruma J, Kitagawa H, et al (2019), "Terbinafine-resistant strain of Trichophyton interdigitale strain isolated from a tinea pedis patient", J Dermatol, 46 (4), pp 351-353.
11. Kintsurashvili N, Kvlividze O, Galdava G (2020), "Prevalence and risk factors of tinea pedis in Georgian defense forces", BMJ Mil Health, 2020 (0), pp 1-4.
12. McAuley WJ, Jones SA (2016), "An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates", Eur J Pharm Biopharm, 102, pp 178-184.
13. Ortonne JP, Korting HC, et al (2006), "Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): A randomized, double-blind, placebo-controlled study", J Eur Acad Dermatol Venereol, 20 (10), pp.1307-1313.
14. Shimoyama H, Sei Y (2019), "2016 epidemiological survey of dermatomycoses in Japan", Med Mycol J, 60 (3), pp 75-82.